Rare Kidney Tumors

Comprehensive Multidisciplinary Management and Emerging Therapies

Rare Kidney Tumors

Comprehensive Multidisciplinary Management and Emerging Therapies

€53.49*

available, deliverable in approx. 2-4 working days

If you require delivery outside DE, AT or CH, please use our contact form for an inquiry.

This book provides clinicians with clear guidance on treatment decision-making in patients with rare kidney cancers. After a brief review on epidemiology, pathology, and biology, each chapter focuses on the multidisciplinary management of a particular tumor subtype using the full range of available cancer therapy modalities, including surgery, radiotherapy, chemotherapy, targeted therapies, and immunotherapy. Emerging therapies and future directions in the management of each cancer subtype are also discussed. The chapters are all written by multidisciplinary teams of international experts comprising at least a urologist, a medical oncologist, and a pathologist.

Rare kidney cancers represent 15% of renal cell carcinomas. In comparison with clear cell renal cell carcinomas, little is known about the biology of such cancers, and few trials have reported on the efficacy of targeted therapies in the metastatic setting. Optimal management thus poses significant challenges and often requires a multidisciplinary team. This book will be an ideal reference guide for all clinicians involved in the care of patients with these orphan tumors.



Introduction
Hereditary RCC Syndromes
Wilms Tumor
Renal Cell Carcinomas in Children
Chromophobe Renal Cell Carcinomas
Papillary Renal Cell Carcinoma
Renal Medullary Carcinomas
Collecting Duct Carcinomas
Translocation Renal Cell Carcinomas
Angiomylipoma
Sarcomatoid and Rhabdoid Renal Cell Carcinoma
Conclusion.
ISBN 978-3-030-07281-0
Article number 9783030072810
Media type Book
Copyright year 2019
Publisher Springer, Berlin
Length IX, 128 pages
Illustrations IX, 128 p. 9 illus., 8 illus. in color.
Language English